BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2594919)

  • 1. Administration of triazolam prior to recovery sleep: effects on sleep architecture, subsequent alertness and performance.
    Balkin TJ; O'Donnell VM; Kamimori GH; Redmond DP; Belenky G
    Psychopharmacology (Berl); 1989; 99(4):526-31. PubMed ID: 2594919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold.
    Spinweber CL; Johnson LC
    Psychopharmacology (Berl); 1982; 76(1):5-12. PubMed ID: 6123129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam.
    Balkin TJ; O'Donnell VM; Wesensten N; McCann U; Belenky G
    Psychopharmacology (Berl); 1992; 107(1):83-8. PubMed ID: 1589566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleepiness/alertness on a simulated night shift following sleep at home with triazolam.
    Walsh JK; Schweitzer PK; Anch AM; Muehlbach MJ; Jenkins NA; Dickins QS
    Sleep; 1991 Apr; 14(2):140-6. PubMed ID: 1866527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zolpidem/triazolam on cognitive performance 12 hours after acute administration.
    Matsunaga Y; Tagaya H; Fukase Y; Hakamata Y; Murayama N; Kumagai Y; Kuroyama M
    Sleep Med; 2018 Dec; 52():213-218. PubMed ID: 30097333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
    Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
    Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daytime carryover of triazolam and flurazepam in elderly insomniacs.
    Carskadon MA; Seidel WF; Greenblatt DJ; Dement WC
    Sleep; 1982; 5(4):361-71. PubMed ID: 6131526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance and rebound during and after short-term administration of quazepam, triazolam and placebo to healthy human volunteers.
    Lee A; Lader M
    Int Clin Psychopharmacol; 1988 Jan; 3(1):31-47. PubMed ID: 2895786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal by caffeine of triazolam-induced impairment of waking function.
    Roehrs T; Zwyghuizen-Doorenbos A; Smith D; Zorick F; Roth T
    Psychopharmacol Ser; 1988; 6():194-202. PubMed ID: 3217412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ethanol, diphenhydramine, and triazolam after a nap.
    Roehrs T; Claiborue D; Knox M; Roth T
    Neuropsychopharmacology; 1993 Nov; 9(3):239-45. PubMed ID: 8280348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine reversal of sleep deprivation effects on alertness and mood.
    Penetar D; McCann U; Thorne D; Kamimori G; Galinski C; Sing H; Thomas M; Belenky G
    Psychopharmacology (Berl); 1993; 112(2-3):359-65. PubMed ID: 7871042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of triazolam in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness.
    Bonnet MH; Arand DL
    J Gerontol; 1990 Jul; 45(4):M139-44. PubMed ID: 2195102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychophysiological effects and dose equivalence of zopiclone and triazolam administered to healthy volunteers. Methodological considerations.
    Gorenstein C; Tavares SM; Gentil V; Peres C; Moreno RA; Dreyfus JF
    Braz J Med Biol Res; 1990; 23(10):941-51. PubMed ID: 2101059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual and acute effects of flurazepam and triazolam in normal subjects.
    Gorenstein C; Gentil V
    Psychopharmacology (Berl); 1983; 80(4):376-9. PubMed ID: 6137859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the effects of zopiclone and triazolam on the sleep of normal subjects].
    Tiberge M; Calvet U; Khayi N; Delahaye C; Arbus L
    Encephale; 1988; 14(4):319-24. PubMed ID: 3058455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep in a sitting position: effect of triazolam on sleep stages and EEG power spectra.
    Aeschbach D; Cajochen C; Tobler I; Dijk DJ; Borbély AA
    Psychopharmacology (Berl); 1994 Mar; 114(2):209-14. PubMed ID: 7838909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.
    Wesensten NJ; Killgore WD; Balkin TJ
    J Sleep Res; 2005 Sep; 14(3):255-66. PubMed ID: 16120100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
    Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
    J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.
    Mitler MM; Seidel WF; van den Hoed J; Greenblatt DJ; Dement WC
    J Clin Psychopharmacol; 1984 Feb; 4(1):2-13. PubMed ID: 6141188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of triazolam in phase-advanced sleep.
    Bonnet MH; Dexter JR; Gillin JC; James SP; Kripke D; Mendelson W; Mitler M
    Neuropsychopharmacology; 1988 Sep; 1(3):225-34. PubMed ID: 3251503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.